Stage IIIA Breast Cancer Terminated Phase 1 Trials for Oxaliplatin (DB00526)

IndicationStatusPhase
DBCOND0028774 (Stage IIIA Breast Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01233505Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid TumorsTreatment